For more up to date announcements, please follow us on Twitter and/or LinkedIn
The symposium will start in
This year's symposium will have multiple sessions covering the latest developments and research on influenza, COVID-19, and RSV. Confirmed international speakers include:
The Symposium program will be available at a later date
Registration via eventbrite here
*Please note that this event will not allow for any virtual access. All sessions will be held in-person*
There will be a minimum of 10 short talk spots available over the course of the Symposium. All speakers must submit abstracts before the closing date, which should relate to work in the fields of influenza, COVID-19 or RSV.
Instructions for submission:
We strongly encourage you to submit an abstract if you have not done so already. The format for these short presentations will be talks lasting a maximum of 10 minutes (with no more than 6 or 7 slides).
Abstracts should be submitted as a Word document on a single page. Minimum Font size 11 pt using Arial or Calibri Fonts. A single figure, table, or graph is acceptable. You must be registered to have your abstract accepted for presentation.
Download the abstract template here.
Please send your abstracts before the deadline at symposium@influenzacentre.org.
Download the flyer here
View the final program booklet here.
This year's symposium focused primarily on COVID-19, but still covered influenza and RSV sessions. The event was attended by over 350 delegates, including representatives from the biomedical, clinical, research, public health, government, and industry sectors. The symposium also welcomed a range of national and international speakers, including:
And many more.
Due to ongoing restrictions in Melbourne, this event was fully virtual. The event was hosted by ASN Events and run via their online platform.
Please contact us here if you have any queries.
View the final program booklet here.
The symposium welcomed a range of national and international speakers, including:
And many more.
Please contact us here if you have any queries.